Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT

Rapoport, Aaron P; Stadtmauer, Edward A; Vogl, Dan T; Weiss, Brendan; Binder-Scholl, Gwendolyn K; Smethurst, Dominic P; Finklestein, Jeffrey; Kulikovskaya, Irina; Gupta, Minnal; Brewer, Joanna E; Bennett, Alan D; Gerry, Andrew B; Pumphrey, Nick J; Tayton-Martin, Helen K; Ribeiro, Lilliam; Badros, Ashraf Z; Yanovich, Saul; Akpek, Gorgun; Kerr, Naseem; Philip, Sunita; Westphal, Sandra; Bruce, Levine L; Jakobsen, Bent K; June, Carl H; Kalos, Michael

doi:10.1186/2051-1426-1-S1-P30

Article metrics
Last updated: Tue, 23 Apr 2024 9:39:32 Z

Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT

Access & Citations

1781

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.